\
&
Contact us
\
&
Contact us
As a co-programmed partnership, Built4People brings together the public sector (the European Commission) and the private sector (ECTP and WorldGBC Europe) with the aim of channelling funding for the built environment, ensuring it is invested in projects which will accelerate innovations towards a sustainable, people-centric transformation of Europe’s built environment sector.
The objectives are scientific (generate holistic innovation for sustainability), economic (revitalise the sector via sustainable operation) and societal (induce behavioural change towards sustainable living). The objectives will be reached through a user-centric approach.
Various topics in the Horizon Europe cluster 5 work programme bear the label "Built4People". These topics contribute to achieving the objectives of this co-programmed partnership.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
Ria.debreucker@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
